Community-acquired fulminant colitis caused by binary toxin-producing Clostridium difficile in Japan.


Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 28 12 2018
accepted: 31 01 2019
pubmed: 16 2 2019
medline: 21 1 2020
entrez: 16 2 2019
Statut: ppublish

Résumé

We report a case of community-acquired fulminant colitis caused by Clostridium difficile in Japan. A 46-year-old woman was diagnosed with severe infectious enterocolitis and was admitted at another hospital. The stool culture was positive for toxigenic C. difficile. Since the patient presented with fulminant C. difficile infection (CDI) with toxic megacolon, respiratory insufficiency, and circulatory failure, she was transferred to Kyorin University Hospital for intensive care. Intubation and antibiotic therapy were performed. The general condition improved with conservative treatment, and she was discharged without sequelae. While the recovered isolate was toxin A and B-positive and binary toxin-positive, it was identified as polymerase chain reaction (PCR) ribotype ts0592 and slpA sequence type ts0592. The isolate was different from PCR ribotype 027 epidemic in Europe and North America. In Japan, binary toxin-producing strains are rare and have not caused an epidemic to date. Furthermore, there are few data on community-acquired CDI in Japan. In this case, a non-elderly woman with no major risk factors such as antibiotic use, administration of proton pump inhibitor and history of gastrointestinal surgery developed community-acquired fulminant CDI caused by the binary toxin-positive strain, and ICU treatment was required. Further studies focusing on the role of binary toxin-positive C. difficile in the severity of community-acquired CDI are necessary.

Identifiants

pubmed: 30767176
doi: 10.1007/s12328-019-00949-z
pii: 10.1007/s12328-019-00949-z
doi:

Substances chimiques

Bacterial Proteins 0
Bacterial Toxins 0
Enterotoxins 0
tcdA protein, Clostridium difficile 0
toxB protein, Clostridium difficile 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-329

Références

Clin Infect Dis. 2000 Oct;31(4):995-1000
pubmed: 11049782
N Engl J Med. 2005 Dec 8;353(23):2442-9
pubmed: 16322602
Euro Surveill. 2007 Jan 11;12(1):E070111.3
pubmed: 17370932
J Clin Microbiol. 2007 Jun;45(6):1963-4
pubmed: 17428945
Clin Infect Dis. 2008 Nov 1;47(9):1162-70
pubmed: 18808358
CMAJ. 2008 Oct 7;179(8):767-72
pubmed: 18838451
Clin Infect Dis. 2010 Jan 15;50(2):194-201
pubmed: 20025526
J Med Microbiol. 2010 May;59(Pt 5):556-62
pubmed: 20133413
J Infect Chemother. 2011 Jul;17 Suppl 1:137-9
pubmed: 21728113
Am J Gastroenterol. 2012 Jan;107(1):89-95
pubmed: 22108454
Nat Genet. 2013 Jan;45(1):109-13
pubmed: 23222960
J Med Microbiol. 2013 Sep;62(Pt 9):1486-9
pubmed: 23558137
Gut Microbes. 2014 Jan-Feb;5(1):15-27
pubmed: 24253566
J Infect Chemother. 2014 Nov;20(11):729-31
pubmed: 25127156
J Med Microbiol. 2015 Oct;64(10):1226-36
pubmed: 26238868
J Clin Microbiol. 1999 Feb;37(2):461-3
pubmed: 9889244

Auteurs

Noriaki Oguri (N)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Akihito Sakuraba (A)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Hiromu Morikubo (H)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Oki Kikuchi (O)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Taro Sato (T)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Soutaro Tokunaga (S)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Shintaro Minowa (S)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Osamu Ikezaki (O)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Tatsuya Mitsui (T)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Miki Miura (M)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Daisuke Saito (D)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Mari Hayashida (M)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Hideaki Mori (H)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan.

Takako Osaki (T)

Department of Infectious Diseases, Kyorin University School of Medicine, Tokyo, Japan.

Shigeru Kamiya (S)

Department of Infectious Diseases, Kyorin University School of Medicine, Tokyo, Japan.

Mitsutoshi Senoh (M)

Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan.

Haru Kato (H)

Department of Bacteriology II, National Institute of Infectious Diseases, Tokyo, Japan.

Tadakazu Hisamatsu (T)

Third Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan. thisamatsu@ks.kyorin-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH